Search Thermo Fisher Scientific
Invitrogen
{{$productOrderCtrl.translations['antibody.pdp.commerceCard.promotion.promotions']}}
{{$productOrderCtrl.translations['antibody.pdp.commerceCard.promotion.viewpromo']}}
{{$productOrderCtrl.translations['antibody.pdp.commerceCard.promotion.promocode']}}: {{promo.promoCode}} {{promo.promoTitle}} {{promo.promoDescription}}. {{$productOrderCtrl.translations['antibody.pdp.commerceCard.promotion.learnmore']}}
SYN-005-11E6 is a humanized monoclonal antibody biosimilar that targets the pertussis toxin subunit 2 which is a component of the toxin produced by Bordetella pertussis the causative agent of whooping cough. This biosimilar is designed for research purposes to inhibit the pertussis toxin thereby offering insights into therapeutic interventions against pertussis infections. SYN-005-11E6 utilizes the IgG1-kappa isotype demonstrating high specificity towards the targeted subunit of the toxin thus contributing to studies aimed at neutralizing pertussis toxin's effects and enhancing vaccine efficacy. This biosimilar is crucial in experimental settings for exploring the potential of monoclonal antibodies in neutralizing bacterial toxins and advancing the development of therapeutic agents against infectious diseases.
仅用于科研。不用于诊断过程。未经明确授权不得转售。